Nav: Home

A comparison between quetiapine and aripiprazole for treatment of schizophrenia

July 13, 2016

Schizophrenia is a common cause of incapacity and is ranked as the third-most-disabling illness subsequent to dementia and quadriplegia. Nearly, 75% of persons with schizophrenia have continuing problems with recurrent psychotic episodes. Antipsychotics are effective in both the acute and chronic (maintenance) treatment of schizophrenia and other psychotic disorders. They differ in their pharmacology, kinetics, overall efficacy/effectiveness and tolerability, but perhaps more importantly, response and tolerability differs between patients. This variability of individual response means that there is no clear first line antipsychotic suitable for all patients. While there is increasing proof that most atypical antipsychotics offer benefits over typical antipsychotics, few long-term trials have openly matched SGAs. Quetiapine is a SGA with small tendency for locomotors side effects. It is prescribed for treatment of schizophrenia and other psychoses. Aripiprazole, a partial agonist of dopamine D2 receptor, is a novel antipsychotic approved for the management of schizophrenia and bipolar I disorder. Since, in comparison with older atypical antipsychotics, like olanzapine and risperidone, aripiprazole and quetiapine are among the newest and safest SGAs, therefore in the present assessment the safety and efficacy of them had been compared with each other in a non-western patient population. In this regard, 50 schizophrenic patients entered into two comparable groups for participation in a 12-week, double-blind study, for random assignment to quetiapine or aripiprazole. Based on the outcomes of the current study, no significant difference was evident between aripiprazole and quetiapine regarding improvement of positive and negative symptoms of schizophrenia. For example, while both of aripiprazole and quetiapine demonstrated some efficacy in alleviation of positive symptoms, their efficacy was not so pronounced with respect to negative symptoms. General psychopathology and insight, too, revealed significant improvement with aripiprazole and quetiapine in comparison to other drugs. Also, in neither groups was there evidence of any significant increase in extrapyramidal adverse effects.
-end-
Reference: Shafti S.S. and Kaviani H., (2016). A Comparison Between Quetiapine and Aripiprazole for Treatment of Schizophrenia: A Double Blind Contrast, Curr Psychopharmacol., DOI:10.2174/

Bentham Science Publishers

Related Schizophrenia Articles:

First physiological test for schizophrenia and depression
Researchers have found a new way of using proteins in nerve cells to identify people with depression and schizophrenia.
The emergence of a new dopamine hypothesis of schizophrenia
Biological Psychiatry presents a special issue, 'The Dopamine Hypothesis of Schizophrenia,' dedicated to recent advances in understanding the role of dopamine signaling in schizophrenia.
Progress in refining the genetic causes of schizophrenia
An international study led by the University of Exeter Medical School has made advances in understanding the ways in which genetic risk factors alter gene function in schizophrenia.
Exercise can tackle symptoms of schizophrenia
Aerobic exercise can significantly help people coping with the long-term mental health condition schizophrenia, according to a new study from University of Manchester researchers.
In search of neurobiological factors for schizophrenia
It is impossible to predict the onset of schizophrenic psychosis.
More Schizophrenia News and Schizophrenia Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Teaching For Better Humans
More than test scores or good grades — what do kids need to prepare them for the future? This hour, guest host Manoush Zomorodi and TED speakers explore how to help children grow into better humans, in and out of the classroom. Guests include educators Olympia Della Flora and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#535 Superior
Apologies for the delay getting this week's episode out! A technical glitch slowed us down, but all is once again well. This week, we look at the often troubling intertwining of science and race: its long history, its ability to persist even during periods of disrepute, and the current forms it takes as it resurfaces, leveraging the internet and nationalism to buoy itself. We speak with Angela Saini, independent journalist and author of the new book "Superior: The Return of Race Science", about where race science went and how it's coming back.